MedTrace Logo

Effect of Vitamin D in Patients With Diabetic Peripheral Neuropathy to Alleviate Pain and Improvement of Symptoms

NCT04984044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2022-03-21

No results posted yet for this study

Summary

Diabetic peripheral neuropathy(DPN) is one of the major complications of diabetes mellitus which accelerates the occurrence of ulceration of diabetic foot and amputation of lower extremities as well as severely affects the quality of life. The treatment of this condition has remained unsatisfactory with a good response to conventional medications. It is now evident that vitamin D deficiency is common in diabetic patients and especially in these patients diagnosed with diabetic peripheral neuropathy. The present research is therefore designed to observe the effect of exogenous administration of vitamin D in diabetic peripheral neuropathy patients of Bangladesh.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Dietary supplement:Vitamin D3 1 capsule of Vitamin D3 (40,000IU) weekly for 8 weeks with antidiabetic drug

DIETARY_SUPPLEMENT

Placebo

1 capsule weekly for 8 weeks with antidiabetic drug

Sponsors & Collaborators

  • Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    lead OTHER

Principal Investigators

  • Zannatul Ferdous, MBBS · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

  • Prof. Md. Sayedur Rahman, MBBS, M Phil, FCPS · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-07
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984044 on ClinicalTrials.gov